Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Disease Markers
Volume 2015, Article ID 548101, 7 pages
http://dx.doi.org/10.1155/2015/548101
Research Article

Chaperonin-Containing t-Complex Protein-1 Subunit β as a Possible Biomarker for the Phase of Glomerular Hyperfiltration of Diabetic Nephropathy

1Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
3School of Pharmacy, National Defense Medical Center, Taipei, Taiwan
4Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
5Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
6Division of Endocrinology and Metabolism, Department of Internal Medicine, Cardinal Tien Hospital, Medical School, Catholic Fu Jen University, Xindian, Taiwan
7Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, No. 325, Section 2, Cheng-Kung Road, Neihu, Taipei 114, Taiwan

Received 24 January 2015; Accepted 26 March 2015

Academic Editor: Mariann Harangi

Copyright © 2015 Chung-Ze Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Retnakaran, C. A. Cull, K. I. Thorne, A. I. Adler, and UKPDS Study Group, “Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74,” Diabetes, vol. 55, pp. 1832–1839, 2006. View at Publisher · View at Google Scholar
  2. E. Ritz, I. Rychlik, F. Locatelli, and S. Halimi, “End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions,” American Journal of Kidney Diseases, vol. 34, no. 5, pp. 795–808, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Jerums, E. Premaratne, S. Panagiotopoulos, and R. J. MacIsaac, “The clinical significance of hyperfiltration in diabetes,” Diabetologia, vol. 53, no. 10, pp. 2093–2104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Bivona, S. Park, and L. M. Harrison-Bernard, “Glomerular filtration rate determinations in conscious type II diabetic mice,” The American Journal of Physiology—Renal Physiology, vol. 300, no. 3, pp. F618–F625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-C. Hwang, L.-C. Chang, Y.-F. Lin, H.-A. Shui, and J.-S. Chen, “Effects of fungal statins on high-glucose-induced mouse mesangial cell hypocontractility may involve filamentous actin, t-complex polypeptide 1 subunit beta, and glucose regulated protein 78,” Translational Research, vol. 156, no. 2, pp. 80–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. N. Ghayur, J. C. Krepinsky, and L. J. Janssen, “Contractility of the renal glomerulus and mesangial cells: lingering doubts and strategies for the future,” Medical Hypotheses and Research, vol. 4, no. 1, pp. 1–9, 2008. View at Google Scholar
  7. T. Nakamura, T. Terajima, T. Ogata et al., “Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide,” Biological & Pharmaceutical Bulletin, vol. 29, no. 6, pp. 1167–1174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. G. Stockelman, J. N. Lorenz, F. N. Smith et al., “Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency,” The American Journal of Physiology—Renal Physiology, vol. 275, no. 1, pp. F154–F163, 1998. View at Google Scholar · View at Scopus
  9. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Wu, J. S. Chen, S. H. Lin, A. Chen, H. K. Sytwu, and Y. F. Lin, “Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events,” Laboratory Animals, vol. 42, no. 3, pp. 350–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. American Diabetes Association, “Standards of medical care in diabetes—2013,” Diabetes Care, vol. 36, supplement 1, pp. S11–S66, 2013. View at Publisher · View at Google Scholar
  12. Y. C. Ma, L. Zuo, J. H. Chen et al., “Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2937–2944, 2006. View at Publisher · View at Google Scholar
  13. Y. Yamamoto, Y. Maeshima, H. Kitayama et al., “Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy,” Diabetes, vol. 53, no. 7, pp. 1831–1840, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. D. L. Eizirik, A. K. Cardozo, and M. Cnop, “The role for endoplasmic reticulum stress in diabetes mellitus,” Endocrine Reviews, vol. 29, no. 1, pp. 42–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Lewis, G. Tian, I. E. Vainberg, and N. J. Cowan, “Chaperonin-mediated folding of actin and tubulin,” The Journal of Cell Biology, vol. 132, no. 1-2, pp. 1–4, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Vallon, K. Richter, R. C. Blantz, S. Thomson, and H. Osswald, “Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption,” Journal of the American Society of Nephrology, vol. 10, no. 12, pp. 2569–2576, 1999. View at Google Scholar · View at Scopus
  17. Z.-M. Lv, Q. Wang, Q. Wan et al., “The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells,” PLoS ONE, vol. 6, no. 7, Article ID e22806, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Wei, P. H. Lane, J. T. Lane, B. J. Padanilam, and S. C. Sansom, “Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes,” Diabetologia, vol. 47, no. 9, pp. 1541–1549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Chagnac, T. Weinstein, A. Korzets, E. Ramadan, J. Hirsch, and U. Gafter, “Glomerular hemodynamics in severe obesity,” The American Journal of Physiology—Renal Physiology, vol. 278, no. 5, pp. F817–F822, 2000. View at Google Scholar · View at Scopus
  20. A. Chagnac, T. Weinstein, M. Herman, J. Hirsh, U. Gafter, and Y. Ori, “The effects of weight loss on renal function in patients with severe obesity,” Journal of the American Society of Nephrology, vol. 14, no. 6, pp. 1480–1486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Bayliss, L. A. Weinrauch, and J. A. D'Elia, “Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy,” Current Diabetes Reports, vol. 12, no. 4, pp. 440–446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Hwang, B. P. Bowen, N. Lefort et al., “Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes,” Diabetes, vol. 59, no. 1, pp. 33–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. S. Schrijver and J. A. Kramps, “Critical factors affecting the diagnostic reliability of enzyme-linked immunosorbent assay formats,” Revue Scientifique et Technique, vol. 17, no. 2, pp. 550–561, 1998. View at Google Scholar · View at Scopus